Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

US Patent 12247057 · Granted Mar 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the characterization of peptide:MHC binding polypeptides2025
Method for the characterization of peptide:MHC binding polypeptides2025
Method for the characterization of peptide:MHC binding polypeptides2025
Peptides and combination of peptides for use in immunotherapy against cancers2025
Peptides and combination of peptides for use in immunotherapy against cancers2025
Peptides and combination of peptides for use in immunotherapy against esophageal2025
Peptides and combination of peptides for use in immunotherapy against esophageal2025
Peptides and combination of peptides for use in immunotherapy against esophageal2025
Peptides and combination of peptides for use in immunotherapy against esophageal2025
Peptides and combination of peptides for use in immunotherapy against esophageal2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025